Cite Filings / SPRO / 0001193125-26-458593

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Spero Therapeutics, Inc. Filed 2026-11-12 Acc 0001193125-26-458593

Documents 1

10-Q Quarterly Report , spro-20260930.htm

Around this filing

2026-11-12 8-K Results of operations
2026-11-12 10-Q Quarterly Report
2026-11-10 4 See Remarks sold 40,851 shares at $1.04 ($42,485)
2026-11-10 4 Options or other derivatives
2026-11-10 3 Initial Statement of Ownership
2026-11-10 8-K Executive or director change
2026-08-12 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading spro-20260930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…